CYCLOBENZAPRINE

Course overview

CYCLOBENZAPRINE IS FDA-APPROVED AS AN ADJUNCT TO REST FOR THE TREATMENT OF MUSCLE SPASMS ASSOCIATED WITH ACUTE, PAINFUL MUSCULOSKELETAL CONDITIONS. CYCLOBENZAPRINE IS A PART OF A GROUP OF MEDICATIONS REFERRED TO AS CYCLICAL ANTIDEPRESSANTS. THESE CYCLICAL ANTIDEPRESSANTS HAVE ROLES IN THE TREATMENT OF DEPRESSION, NEUROPATHIC PAIN, MIGRAINE PROPHYLAXIS, ATTENTION DEFICIT HYPERACTIVE DISORDER AS WELL AS POTENTIAL MUSCLE RELAXATION PROPERTIES. THIS ACTIVITY REVIEWS THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, TOXICITY, DOSING, PHARMACODYNAMICS, AND MONITORING OF CYCLOBENZAPRINE, FOR MEMBERS OF THE INTERPROFESSIONAL TEAM WHO WILL POTENTIALLY PRESCRIBE OR ENCOUNTER PATIENTS TAKING CYCLOBENZAPRINE.